Chen‐Chun Lin
Impact in
- Hepatology top 2%
- Hepatocellular Carcinoma Treatment and Prognosis
- Hepatitis C virus research
Papers in
- Hepatology 32
- Hepatocellular Carcinoma Treatment and Prognosis 29
- Hepatitis C virus research 6
- Epidemiology 12
- Liver Disease Diagnosis and Treatment 8
- Hepatitis B Virus Studies 6
- Co-authors
- Wei‐Ting Chen (24 shared papers)Shi‐Ming Lin (14 shared papers)Shi‐Ming Lin (18 shared papers)Chun‐Yen Lin (18 shared papers)Wei Teng (18 shared papers)I‐Shyan Sheen (12 shared papers)Wen‐Juei Jeng (10 shared papers)B. Hwang (1 shared paper)
- Journals
- Journal of Viral Hepatitis (3 papers)Cancers (3 papers)Liver Cancer (3 papers)Journal of Hepatology (3 papers)Journal of Vascular and Interventional Radiology (2 papers)
- Partner nations
- TaiwanUnited StatesSingapore
In The Last Decade
Chen‐Chun Lin
42 papers receiving 675 citations
Peers
Comparison fields: 5 of 57
- Hepatology 382
- Cancer Research 67
- Epidemiology 128
- Pulmonary and Respiratory Medicine 97
- Oncology 80
Countries citing papers authored by Chen‐Chun Lin
This map shows the geographic impact of Chen‐Chun Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chen‐Chun Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chen‐Chun Lin more than expected).
Fields of papers citing papers by Chen‐Chun Lin
This network shows the impact of papers produced by Chen‐Chun Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chen‐Chun Lin. The network helps show where Chen‐Chun Lin may publish in the future.
Co-authors
The 25 scholars most cited alongside Chen‐Chun Lin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 49 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2015 | 90 | |
| 2 | 1993 | 76 | |
| 3 | 2015 | 43 | |
| 4 | 2019 | 42 | |
| 5 | 2017 | 40 | |
| 6 | 2007 | 33 | |
| 7 | 2013 | 28 | |
| 8 | 2022 | 28 | |
| 9 | 2010 | 22 | |
| 10 | Alpha-fetoprotein response at different time-points is associated with efficacy of nivolumab monotherapy for unresectable hepatocellular carcinoma. | 2021 | 21 |
| 11 | Proton beam radiotherapy combined with anti-PD1/PDL1 immune checkpoint inhibitors for advanced hepatocellular carcinoma. | 2022 | 19 |
| 12 | 2010 | 16 | |
| 13 | 2014 | 16 | |
| 14 | 2018 | 16 | |
| 15 | 2011 | 15 | |
| 16 | 2024 | 13 | |
| 17 | 2023 | 13 | |
| 18 | 2017 | 11 | |
| 19 | 2022 | 11 | |
| 20 | 2017 | 10 |
About Chen‐Chun Lin
Chen‐Chun Lin is a scholar working on Hepatology, Epidemiology, Cancer Research, Critical Care and Intensive Care Medicine and Pulmonary and Respiratory Medicine, having authored 49 papers that have together received 686 indexed citations. Recurring topics across this work include Hepatocellular Carcinoma Treatment and Prognosis (29 papers), Liver Disease Diagnosis and Treatment (8 papers), Hepatitis B Virus Studies (6 papers), Hepatitis C virus research (6 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (3 papers), Pancreatic and Hepatic Oncology Research (3 papers), Intensive Care Unit Cognitive Disorders (3 papers) and Cancer, Lipids, and Metabolism (3 papers). The work is most often cited by research in Hepatology (382 citations), Cancer Research (67 citations), Epidemiology (128 citations), Pulmonary and Respiratory Medicine (97 citations) and Oncology (80 citations). Chen‐Chun Lin has collaborated with scholars based in Taiwan, United States and Singapore. Frequent co-authors include Wei‐Ting Chen, Shi‐Ming Lin, Shi‐Ming Lin, Chun‐Yen Lin, Wei Teng, I‐Shyan Sheen, Wen‐Juei Jeng, B. Hwang, Ching‐Yuang Lin and Benjamin N. Chiang. Their work appears in journals such as Journal of Viral Hepatitis, Cancers, Liver Cancer, Journal of Hepatology and Journal of Vascular and Interventional Radiology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.